|Articles|October 2, 2018
Release of ADDPLAN neo Announced by ICON
Advertisement
ICON, a provider of drug development services, announced the release of ADDPLAN® neo, providing a technology platform for design, simulation, and analysis of adaptive clinical trials. The new release combines three modules, ADDPLAN® BASE, ADDPLAN® MC, and ADDPLAN® DF to become integrated under one robust framework.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
2
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
3
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
4
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
5